StemCell Therapy

CAMBRIDGE, Mass. Gene therapy pioneer Dr. James Wilson is disappointed by the progress in his field and expects current therapies and technologies to be soon surpassed by new approaches.

In five years, when we look back on the way were executing on gene therapy now, were going to realize that things are going to be very different, Wilson said at the STAT Summit on Thursday. The way in which were going to treat Duchenne muscular dystrophy, potentially cure it, is not the way in which its being evaluated in the clinic now.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

See the rest here:
Gene therapy pioneer: Field is behind, and delivery tech is 'embarrassing' - STAT

This entry was posted on November 26, 2019 at 9:44 am and is filed under Gene therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |